MedPath

Sun Pharmaceutical Industries (Europe) B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

231

CIMA_AEMPS:221
EMA:10

Drug Approvals

Sitagliptin / Metformin hydrochloride Sun

Authorization Status
Authorised
Approval Date
Mar 31, 2023
EMA

Teriparatide Sun

Authorization Status
Authorised
Approval Date
Nov 18, 2022
EMA

Ertapenem SUN

Authorization Status
Authorised
Approval Date
Jul 15, 2022
EMA

Sitagliptin SUN

Authorization Status
Authorised
Approval Date
Dec 9, 2021
EMA

Bortezomib Sun

Authorization Status
Authorised
Approval Date
Jul 22, 2016
EMA

Odomzo

Authorization Status
Authorised
Approval Date
Aug 14, 2015
EMA

Atosiban SUN

Authorization Status
Authorised
Approval Date
Jul 31, 2013
EMA

Levetiracetam Sun

Authorization Status
Authorised
Approval Date
Dec 14, 2011
EMA

Temozolomide Sun

Authorization Status
Authorised
Approval Date
Jul 13, 2011
EMA

Temozolomide Sun

Authorization Status
Authorised
Approval Date
Jul 13, 2011
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.